Active Arm, Zota Cohort 2 for Coronavirus
This trial is testing a new drug to see if it is safe and effective against mild or moderate cases of COVID-19.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Does this research project involve elderly participants?
"This study is looking for 18 to 64-year-old patients that meet the inclusion criteria. Out of the 1,147 ongoing clinical trials, 150 are for minors and 997 are for seniors."
Are there other published papers that feature Active Arm, Zota Cohort 2?
"As of right now, there are 2 ongoing clinical trials studying Active Arm, Zota Cohort 2. 0 of these trials are in Phase 3. Although many of the trials are based in Cullman, Alabama, there are a total of 19 clinical trial sites for Active Arm, Zota Cohort 2."
How many subjects are enroled in this research project?
"36 individuals that meet the pre-determined inclusion criteria must enroll in this clinical trial. These potential participants can reside near Pinnacle Research Group in Anniston, Maryland or National Institute of Allergy and Infectious Diseases in Bethesda, Florida."
What precedent does this trial set for future research?
"As of now, there are 2 ongoing trials for Active Arm, Zota Cohort 2 in 17 metropolises and 1 nation. The first research project for Active Arm, Zota Cohort 2 was in 2019. The 198 participants completed Phase 1 & 2 drug approval. Since then, 18244 other trials have been completed."
Are there different facilities testing this procedure within the state?
"There are a total of 7 research sites running this study, including Pinnacle Research Group in Anniston, National Institute of Allergy and Infectious Diseases in Bethesda, and National Institutes of Health Clinical Center in Bradenton."
Are we looking for participants in this experiment currently?
"Yes, this is an active recruitment according to the information on clinicaltrials.gov. This trial was posted on 7/1/2021 and was last edited on 10/5/2022. They are recruiting for 36 patients at 7 locations."
Who can sign up for this experiment?
"Eligible individuals for this study must suffer from a virus disease, be aged 18-64, and there are only 36 total spots open."
Has Active Arm, Zota Cohort 2 received FDA approval?
"Active Arm, Zota Cohort 2 falls into the Phase 1 category, which means that, according to our team's estimation, it ranks a 1 on the safety scale."